Related Experiment Video
Updated: Oct 22, 2025
Human Pluripotent Stem Cell Based Developmental Toxicity Assays for Chemical Safety Screening and Systems Biology Data Generation
Published on: June 17, 2015
Three regulatory compliant test systems show no signs of MDMA-related genotoxicity
Isaac Victor Cohen1, Laken Barber2,3, Tyson Paul Dubnicka4
1Clinical Pharmacology and Therapeutics (CPT) Postdoctoral Training Program, University of California San Francisco, San Francisco, CA, USA.
Abstract:
3,4 Methylenedioxymethamphetamine (MDMA)-assisted therapy has been recently found to be highly effective for treatment of posttraumatic stress disorder (PTSD). Previous studies have been inconclusive in elucidating potential MDMA genotoxicity. We performed three regulatory compliant studies to investigate the potential of genotoxic effects of MDMA treatment in humans: (1) an in vitro bacterial reverse mutation (Ames) assay, (2) an in vitro chromosome aberration test in Chinese hamster ovary cells, and (3) an in vivo micronucleus study in male Sprague Dawley rats. MDMA was found to not have genotoxic effects in any of the assays at or above clinically relevant concentrations.
Insights
3,4-Methylenedioxymethamphetamine (MDMA) therapy shows promise for posttraumatic stress disorder (PTSD). Rigorous studies found no genotoxic effects of MDMA at clinically relevant doses, supporting its safety for therapeutic use.
Area of Science:
- Pharmacology
- Toxicology
- Psychiatry
Background:
- 3,4-Methylenedioxymethamphetamine (MDMA)-assisted therapy is emerging as a potent treatment for posttraumatic stress disorder (PTSD).
- Previous research on the genotoxicity of MDMA has yielded inconclusive results, necessitating further investigation.
Purpose of the Study:
- To comprehensively evaluate the potential genotoxic effects of MDMA treatment in humans.
- To address the inconclusive findings from prior studies regarding MDMA's genotoxicity.
Main Methods:
- Conducted three regulatory-compliant genotoxicity assays: an in vitro bacterial reverse mutation (Ames) assay.
- Performed an in vitro chromosome aberration test using Chinese hamster ovary cells.
- Carried out an in vivo micronucleus study in male Sprague Dawley rats.
Main Results:
- MDMA demonstrated no genotoxic effects in the in vitro bacterial reverse mutation (Ames) assay.
- The in vitro chromosome aberration test in Chinese hamster ovary cells showed no evidence of genotoxicity.
- The in vivo micronucleus study in Sprague Dawley rats indicated no genotoxic potential.
Conclusions:
- MDMA treatment did not exhibit genotoxic effects in any of the conducted assays.
- Findings support the safety profile of MDMA at concentrations relevant to clinical therapeutic use.
- This research contributes to the understanding of MDMA's safety in the context of PTSD treatment.
